Literature DB >> 1345675

Recovery of mononuclear cell subsets after bone marrow transplantation: overabundance of CD4+CD8+ dual-positive T cells reminiscent of ontogeny.

J Storek1, S Ferrara, C Rodriguez, A Saxon.   

Abstract

Patients after bone marrow transplantation are immunodeficient for months to years. To understand better the pathogenesis of this immunodeficiency, we studied quantitative reconstitution of blood monocytes, natural killer (NK) cells, T cells, and B cells at 2-22 months post-transplant. The results indicate monocyte and NK counts generally recover within 2 months, followed by CD4-CD8+ T cell, B cell, and finally (after > 1 year) CD4+CD8- T cell numbers. Dual-positive CD4+CD8+ T cells (which were barely detectable in normal adults), CD4-CD8+ T cells and B cells transiently reached supranormal levels during recovery. Both CD4+CD8- and CD4-CD8+ T cells were larger than controls throughout the 2-year follow up. Comparison with neonatal and infant mononuclear cell subsets suggested the reconstitution of CD4+CD8+ T cells and B cells is similar to ontogeny. In contrast, the reconstitution of CD4+CD8- T cells did not resemble ontogeny.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1345675     DOI: 10.1089/scd.1.1992.1.303

Source DB:  PubMed          Journal:  J Hematother        ISSN: 1061-6128


  3 in total

1.  Monocyte-mediated T-cell suppression and augmented monocyte tryptophan catabolism after human hematopoietic stem-cell transplantation.

Authors:  Ursula Hainz; Petra Obexer; Christiana Winkler; Peter Sedlmayr; Osamu Takikawa; Hildegard Greinix; Anita Lawitschka; Ulrike Pötschger; Dietmar Fuchs; Stephan Ladisch; Andreas Heitger
Journal:  Blood       Date:  2005-01-27       Impact factor: 22.113

2.  Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques.

Authors:  Ruth Seggewiss; Karin Loré; F Javier Guenaga; Stefania Pittaluga; Joseph Mattapallil; Catherine K Chow; Richard A Koup; Kevin Camphausen; Martha C Nason; Martin Meier-Schellersheim; Robert E Donahue; Bruce R Blazar; Cynthia E Dunbar; Daniel C Douek
Journal:  Blood       Date:  2007-03-20       Impact factor: 22.113

3.  Differential responsiveness to immunoablative therapy in refractory rheumatoid arthritis is associated with level and avidity of anti-cyclic citrullinated protein autoantibodies: a case study.

Authors:  Y K Onno Teng; Robert J Verburg; Kirsten N Verpoort; Gwendolyn M P Diepenhorst; Ingeborg M Bajema; Maarten J D van Tol; Els C M Jol-van der Zijde; Rene E M Toes; Tom W J Huizinga; Jacob M van Laar
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.